Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Laura, Kallay"'
Autor:
Abigail Koehler, Aniruddha Karve, Pankaj Desai, Jack Arbiser, David R. Plas, Xiaoyang Qi, Renee D. Read, Atsuo T. Sasaki, Vaibhavkumar S. Gawali, Donatien K. Toukam, Debanjan Bhattacharya, Laura Kallay, Daniel A. Pomeranz Krummel, Soma Sengupta
Publikováno v:
Pharmaceuticals, Vol 14, Iss 2, p 99 (2021)
Glioblastoma multiforme (GBM) is a highly malignant primary brain tumor. The current standard of care for GBM is the Stupp protocol which includes surgical resection, followed by radiotherapy concomitant with the DNA alkylator temozolomide; however,
Externí odkaz:
https://doaj.org/article/828b4f2787c44da2b744a2df9d8086fd
Autor:
Daniel Pomeranz Krummel, Peter J. Stambrook, Donatien K Toukam, Laura Kallay, Soma Sengupta, Debanjan Bhattacharya, Vaibhavkumar S. Gawali, Abigail Koehler
Publikováno v:
Exp Biol Med (Maywood)
γ-aminobutyric acid or GABA is an amino acid that functionally acts as a neurotransmitter and is critical to neurotransmission. GABA is also a metabolite in the Krebs cycle. It is therefore unsurprising that GABA and its receptors are also present o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8fc3884f9990c5a305037144a038e13
https://doi.org/10.1177/15353702211032549
https://doi.org/10.1177/15353702211032549
Autor:
Jeanne Kowalski, Milota Kaluzova, Andre J. Burnham, Daniel Pomeranz Krummel, Mario Medvedovic, Tahseen H. Nasti, Soma Sengupta, Mohammad K. Khan, Yichun Cao, Maxwell Xu, Jeffrey M. Switchenko, Johannes C. Melms, Andrew Jenkins, Dan Ionascu, James M. Cook, Laura Kallay, David H. Lawson, Guanguan Li, Taukir Ahmed, Debanjan Bhattacharya, Benjamin Izar
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 109:1040-1053
Purpose Most patients with metastatic melanoma show variable responses to radiation therapy and do not benefit from immune checkpoint inhibitors. Improved strategies for combination therapy that leverage potential benefits from radiation therapy and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e17b725a1ff9fc1519bdd3e966777143
https://doi.org/10.1016/j.ijrobp.2020.10.025
https://doi.org/10.1016/j.ijrobp.2020.10.025
Autor:
Donatien Kamdem Toukam, Debanjan Bhattacharya, Vaibhavkumar Gawali, Laura Kallay, Aniruddha Karve, Pankaj Desai, James Cook, Taukir Ahmed, Trajan Dan Ionascu, Susheela Tridandapani, Daniel Pomeranz Krummel, Soma Sengupta
Publikováno v:
Neuro-Oncology. 24:vii246-vii247
Standard-of-care for melanoma brain metastases is moving to stereotactic radiosurgery (SRS) with immunotherapy. Although this combined approach shows improved patient survival, the responses are not durable. SRS can also cause adverse reactions such
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ed789466c99a501dd2ba83a097df95e
https://doi.org/10.1093/neuonc/noac209.953
https://doi.org/10.1093/neuonc/noac209.953
Autor:
Matthew Schniederjan, Jeffrey J. Olson, Havi Rosen, Benjamin Izar, Brent D. Weinberg, Daniel Pomeranz Krummel, Robert H. Press, Mohammad K. Khan, Maxwell Xu, David H. Lawson, Manali Rupji, Lindsey Lowder, Soma Sengupta, Stewart G. Neill, Jeanne Kowalski, Jing Su, Tahseen H. Nasti, Walter J. Curran, Laura Kallay
Publikováno v:
Int J Radiat Oncol Biol Phys
Purpose Melanoma brain metastases (MBM) occur in ∼50% of melanoma patients. Although both radiation therapy (RT) and immune checkpoint inhibitor (ICI) are used alone or in combination for MBM treatment, the role of this combination and how these tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1309baf3b39317d5ddab64db9a945447
https://doi.org/10.1016/j.ijrobp.2020.01.043
https://doi.org/10.1016/j.ijrobp.2020.01.043
Autor:
Debanjan Bhattacharya, Riccardo Barille, Donatien Kamdem Toukam, Vaibhavkumar Gawali, Laura Kallay, Taukir Ahmed, James Cook, Aniruddha Karve, Pankaj Desai, Mario Medvedovic, Daniel Pomeranz Krummel, Soma Sengupta
Publikováno v:
Neuro-Oncology. 24:vii247-vii247
Most advanced-stage non-small cell lung cancer (NSCLC) patients have brain metastases that render a dismal prognosis. Treatment of metastatic brain lesions from NSCLC and other tumor types include radiation as part of a multimodal treatment regimen.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3539761b656ec7408395f797a0c1caf
https://doi.org/10.1093/neuonc/noac209.954
https://doi.org/10.1093/neuonc/noac209.954
Autor:
Alexandra Ross, Manali Rupji, Laura Kallay, Xin Wang, Taukir Ahmed, Yanxin Pei, Soma Sengupta, Havva Keskin, Jeanne Kowalski, James M. Cook, Andrew Jenkins, Olivia A. Moody, Maxwell Xu, Farjana Rashid, Guanguan Li, Michael D. Taylor, T. Austin Nuckols, Daniel Pomeranz Krummel, Kirsten A. Cottrill, Deborah E. Martinson, Michael Rajesh Stephen, Frank Tranghese
Publikováno v:
Journal of Neuro-Oncology. 142:411-422
Pediatric brain cancer medulloblastoma (MB) standard-of-care results in numerous comorbidities. MB is comprised of distinct molecular subgroups. Group 3 molecular subgroup patients have the highest relapse rates and after standard-of-care have a 20%
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bde754cadbc924ab23706432ecd6851e
https://doi.org/10.1007/s11060-019-03115-0
https://doi.org/10.1007/s11060-019-03115-0
Autor:
Renee Read, Donatien K Toukam, Soma Sengupta, Abigail Koehler, Xiaoyang Qi, Aniruddha Karve, David R. Plas, Vaibhavkumar S. Gawali, Daniel Pomeranz Krummel, Jack L. Arbiser, Atsuo T. Sasaki, Laura Kallay, Pankaj B. Desai, Debanjan Bhattacharya
Publikováno v:
Pharmaceuticals
Pharmaceuticals, Vol 14, Iss 99, p 99 (2021)
Pharmaceuticals, Vol 14, Iss 99, p 99 (2021)
Glioblastoma multiforme (GBM) is a highly malignant primary brain tumor. The current standard of care for GBM is the Stupp protocol which includes surgical resection, followed by radiotherapy concomitant with the DNA alkylator temozolomide; however,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9196b1d938b3e98fdc8e750a1322e88e
https://pubmed.ncbi.nlm.nih.gov/33525329
https://pubmed.ncbi.nlm.nih.gov/33525329
Autor:
Daniel A, Pomeranz Krummel, Tahseen H, Nasti, Milota, Kaluzova, Laura, Kallay, Debanjan, Bhattacharya, Johannes C, Melms, Benjamin, Izar, Maxwell, Xu, Andre, Burnham, Taukir, Ahmed, Guanguan, Li, David, Lawson, Jeanne, Kowalski, Yichun, Cao, Jeffrey M, Switchenko, Dan, Ionascu, James M, Cook, Mario, Medvedovic, Andrew, Jenkins, Mohammad K, Khan, Soma, Sengupta
Publikováno v:
Int J Radiat Oncol Biol Phys
PURPOSE: Most metastatic melanoma patients show variable responses to radiotherapy and do not benefit from immune checkpoint inhibitors (ICIs). Improved strategies for combination therapy that leverage potential benefits from radiotherapy and ICI are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::67dcefedeb4d2146ff4c45431ef817bf
https://pubmed.ncbi.nlm.nih.gov/33289666
https://pubmed.ncbi.nlm.nih.gov/33289666
Autor:
Christopher L Brett, Laura Kallay, Zhaolin Hua, Richard Green, Anthony Chyou, Yongqiang Zhang, Todd R Graham, Mark Donowitz, Rajini Rao
Publikováno v:
PLoS ONE, Vol 6, Iss 3, p e17619 (2011)
Protons, the smallest and most ubiquitous of ions, are central to physiological processes. Transmembrane proton gradients drive ATP synthesis, metabolite transport, receptor recycling and vesicle trafficking, while compartmental pH controls enzyme fu
Externí odkaz:
https://doaj.org/article/4c4a7e183a0740b890c3fc5bd8256877